These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases. Muller G; Devilliers H; Besancenot JF; Manckoundia P Geriatr Gerontol Int; 2016 Jun; 16(6):679-85. PubMed ID: 26081629 [TBL] [Abstract][Full Text] [Related]
7. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis. Broder MS; Sarsour K; Chang E; Collinson N; Tuckwell K; Napalkov P; Klearman M Semin Arthritis Rheum; 2016 Oct; 46(2):246-252. PubMed ID: 27378247 [TBL] [Abstract][Full Text] [Related]
8. Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids. Rubinow A; Brandt KD; Cohen AS; Sack B Ann Ophthalmol; 1984 Mar; 16(3):258-60, 262, 264-5. PubMed ID: 6712068 [TBL] [Abstract][Full Text] [Related]
9. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707 [TBL] [Abstract][Full Text] [Related]
10. Two cases of recurrent stroke in treated giant cell arteritis: diagnostic and therapeutic dilemmas. Fitzgerald AJ; Ironside JW; Summers DM; Dennis MS; McRorie ER J Clin Rheumatol; 2010 Aug; 16(5):225-8. PubMed ID: 20661069 [TBL] [Abstract][Full Text] [Related]
11. Osteoporosis prophylaxis prescribing patterns in ophthalmology patients treated with long-term corticosteroids. Walker RA; Hall RB; Pekush RD; Taylor-Gjevre RM Can J Ophthalmol; 2010 Feb; 45(1):81-2. PubMed ID: 20130720 [No Abstract] [Full Text] [Related]
12. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database. Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397 [TBL] [Abstract][Full Text] [Related]
13. Deterioration of giant cell arteritis with corticosteroid therapy. Staunton H; Stafford F; Leader M; O'Riordain D Arch Neurol; 2000 Apr; 57(4):581-4. PubMed ID: 10768635 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids. Andersson R; Malmvall BE; Bengtsson BA Acta Med Scand; 1986; 220(4):361-4. PubMed ID: 3799241 [TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in patients with temporal arteritis and polymyalgia rheumatica. Mateo L; Nolla JM; Rozadilla A; Rodríguez-Moreno J; Niubó R; Valverde J; Roig-Escofet D J Rheumatol; 1993 Aug; 20(8):1369-73. PubMed ID: 8230021 [TBL] [Abstract][Full Text] [Related]
17. Inhaled and oral corticosteroids: their effects on bone mineral density in older adults. Marystone JF; Barrett-Connor EL; Morton DJ Am J Public Health; 1995 Dec; 85(12):1693-5. PubMed ID: 7503347 [TBL] [Abstract][Full Text] [Related]
18. Prevention of steroid-induced osteoporosis is not unique to ophthalmology. Pope J; McKeown E Can J Ophthalmol; 2010 Feb; 45(1):10-2. PubMed ID: 20130702 [No Abstract] [Full Text] [Related]
19. [Bone mineral density after treatment for nasal polyposis]. Norès JM; Mutschler C; Malinvaud D; Halimi P; Bonfils P Presse Med; 2005 Aug; 34(14):1001-4. PubMed ID: 16225252 [TBL] [Abstract][Full Text] [Related]
20. [Giant-cell arteritis: the clinico-biological manifestations and the complications secondary to steroid treatment]. de la Casa Monje R; Barbado Hernández FJ; Peña Sánchez de Rivera JM; Domínguez Castellano A; Sendino Revuelta A; González-Anglada I; Vázquez Rodríguez JJ An Med Interna; 1991 Apr; 8(4):161-5. PubMed ID: 1912167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]